Search

everythinglearnresearchcommunity

for

Search:↓

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

Granulomatous alopecia may be a distinct subtype of alopecia areata.

A 14-year-old boy is the youngest person reported with a rare, benign tumor related to hair follicles, usually found in older people.

Hair follicle counts and ratios are helpful in diagnosing hair loss types, but should be used with other specific features for accurate diagnosis.

Scarring folliculitis type of acne inversa is linked to specific symptoms and lifestyle factors like smoking and being overweight.

Erosive lichen sclerosus is a distinct subtype with specific skin features, and treatment led to complete resolution in half of the cases.

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Scalp melanoma is often diagnosed late in people with hair loss, leading to worse outcomes.

Alopecia areata incognita causes sudden hair loss but usually improves with topical steroids.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

APKH in young males may signal early hair loss and needs early attention.

Tailored combination therapy improves non-scarring alopecia outcomes.

The study concluded that careful examination is key to differentiate between lipidized fibrous histiocytoma and juvenile xanthogranuloma.

Dr. Connelly agrees that linear basal cell carcinomas might be more aggressive but highlights the study's lack of clear criteria to identify them.

The document concludes that detailed clinical descriptions of seven family cases help understand dominant dystrophic epidermolysis bullosa's symptoms and inheritance.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

PSENEN gene mutations can cause both Dowling-Degos disease and acne inversa.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

These hair loss conditions might be part of a spectrum, not separate issues.

The study concluded that a 'Swiss cheese' pattern in hair follicles is a useful sign for diagnosing alopecia areata.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Trichoblastomas in rabbits are linked to uncontrolled embryonic hair growth and have distinct histological features.

New hair loss subtype found, mimics common baldness.